Abstract:CRISPR-Cas12a (previously named Cpf1) is a prokaryotic deoxyribonuclease that can be programmed with an RNA guide to target complementary DNA sequences. Upon binding of the target DNA, Cas12a induces a nick in each of the target DNA strands, yielding a double-stranded DNA break. In addition to inducing cis-cleavage of the targeted DNA, target DNA binding induces trans-cleavage of non-target DNA. As such, Cas12a-RNA guide complexes can provide sequence-specific immunity against invading nucleic acids such as bacteriophages and plasmids. Akin to CRISPR-Cas9, Cas12a has been repurposed as a genetic tool for programmable genome editing and transcriptional control in both prokaryotic and eukaryotic cells. In addition, its trans-cleavage activity has been applied for high-sensitivity nucleic acid detection. Despite the demonstrated value of Cas12a for these applications, the exact molecular mechanisms of both cis- and trans-cleavage of DNA were not completely understood. Recent studies have revealed mechanistic details of Cas12a-mediates DNA cleavage: base pairing of the RNA guide and the target DNA induces major conformational changes in Cas12a. These conformational changes render Cas12a in a catalytically activated state in which it acts as deoxyribonuclease. This deoxyribonuclease activity mediates cis-cleavage of the displaced target DNA strand first, and the RNA guide-bound target DNA strand second. As Cas12a remains in the catalytically activated state after cis-cleavage, it subsequently demonstrates trans-cleavage of non-target DNA. Here, I review the mechanistic details of Cas12a-mediated cis- and trans-cleavage of DNA. In addition, I discuss how bacteriophage-derived anti-CRISPR proteins can inhibit Cas12a activity.

CRISPR-controlled proteases

Engineering Anti‐CRISPR Proteins to Create CRISPR‐Cas Protein Switches for Activatable Genome Editing and Viral Protease Detection

Proteasomal control of anti-CRISPRs for the regulation of CRISPR/Cas9 activity using Cas9-ACROBAT

Making the cut(s): how Cas12a cleaves target and non-target DNA

Engineering Anti‐CRISPR Proteins to Create Cas12a Protein Switches for Activatable Genome Editing and Viral Protease Detection

Craspase Orthologs Cleave a Nonconserved Site in Target Protein Csx30

CRISPR-Cas9 Structures and Mechanisms.

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes

Progress of CRISPR-based programmable RNA manipulation and detection.

Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

CRISPR–Cas-mediated transcriptional control and epi-mutagenesis

RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex

Unravelling the structural and mechanistic basis of CRISPR–Cas systems

Anti-CRISPR protein applications: natural brakes for CRISPR-Cas technologies

CRISPR RNA-guided DNA cleavage by reconstituted Type I-A immune effector complexes

An alpha-helical lid guides the target DNA toward catalysis in CRISPR-Cas12a

Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex

A comprehensive appraisal of mechanism of anti-CRISPR proteins: an advanced genome editor to amend the CRISPR gene editing

Precise transcript targeting by CRISPR-Csm complexes

Exploiting CRISPR/Cas: Interference Mechanisms and Applications